# CMIT signs six-year contract with Eli Lilly/AVID for PET radiopharmaceutical

CMIT has signed a six-year contract with Eli Lilly/AVID to produce F-18 labeled AV-1451 PET radiopharmaceutical for early detection of Alzheimer's disease at its Southern Isotopes facility in Shreveport.

- Type: Contract
- Announced: 2018-06-13
- Where: Shreveport, Louisiana, United States
- Status: announced
- Products: F-18 labeled AV-1451 PET radiopharmaceutical
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CMIT](https://endata.com/companies/32563.md) (supplier)
- [Eli Lilly](https://endata.com/companies/32564.md) (customer)
- [AVID Radiopharmaceuticals](https://endata.com/companies/32565.md) (customer)

## Sources

- [brfla.org](https://www.brfla.org/cmit-manufactures-pet-radiopharmaceuticals-to-detect-neurodegenerative-diseases/), 2018-06-13: "CMIT has signed a six-year contract with Eli Lilly/ AVID to produce a PET radiopharmaceutical for early detection of Alzheimer’s disease."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.